Why is Bliss GVS Pharma falling/rising?

As of 24-Sep, Bliss GVS Pharma Ltd's stock price is currently at 151.40, reflecting a slight increase of 0.25 (0.17%). The stock has shown mixed performance recently, with a 1-week decline of 0.85% and a 1-month drop of 6.22%. Despite this, it has outperformed its sector today by 0.62%. The stock is trading above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 35.32% compared to the 5-day average. The company maintains a low debt-to-equity ratio and has a fair valuation, but its profits have decreased by 3.6% over the past year, despite generating a 10.63% return.
In the broader market context, Bliss GVS Pharma's recent performance contrasts with the Sensex, which has seen a decline of 1.18% over the past week and a slight increase of 0.50% over the past month. While the stock has outperformed the benchmark over the last year and consistently generated returns over the past three years, its year-to-date performance shows a decline of 8.05%, compared to the Sensex's gain of 4.58%. This indicates that while the stock has had periods of strong performance, recent trends suggest challenges that may be affecting investor confidence and participation.